Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference

Rhea-AI Summary

Quest Diagnostics (NYSE: DGX) announced that Chairman, CEO and President Jim Davis will deliver a presentation at the William Blair 45th Annual Growth Stock Conference in Chicago. The presentation is scheduled for June 3, 2025, at 11:00 a.m. Eastern Time.

During the presentation, Davis will discuss the company's strategy, performance, and current market trends. Investors can access the live webcast through Quest's investor relations page at ir.QuestDiagnostics.com. The archived version will be available within 24 hours after the event and remain accessible until July 3, 2025.

[]

News Market Reaction – DGX

+0.88%

+0.88% Session move

In the trading session that priced this news, DGX gained 0.88%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECAUCUS, N.J., May 16, 2025 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that Jim Davis, Chairman, CEO and President, will speak on the company's strategy, performance and the latest market developments and trends during a presentation at the William Blair 45^th Annual Growth Stock Conference in Chicago on Tuesday, June 3, 2025, at 11:00 a.m. Eastern Time.

The presentation session will be webcast live during the conference on the company's investor relations page, which can be accessed at ir.QuestDiagnostics.com. In addition, the archived webcast will be available within 24 hours after the conclusion of the live event and will remain available until July 3, 2025.

About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world. www.QuestDiagnostics.com.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-william-blair-45th-annual-growth-stock-conference-302458004.html

SOURCE Quest Diagnostics

FAQ

When is Quest Diagnostics (DGX) presenting at the William Blair Conference 2025?

Quest Diagnostics will present at the William Blair Conference on Tuesday, June 3, 2025, at 11:00 a.m. Eastern Time.

Who will represent Quest Diagnostics (DGX) at the William Blair Conference 2025?

Jim Davis, Quest Diagnostics' Chairman, CEO and President, will represent the company at the conference.

How can investors watch Quest Diagnostics' (DGX) William Blair Conference presentation?

Investors can watch the live webcast on Quest's investor relations page at ir.QuestDiagnostics.com. An archived version will be available for 30 days until July 3, 2025.

What topics will Quest Diagnostics (DGX) discuss at the William Blair Conference 2025?

The presentation will cover Quest Diagnostics' strategy, performance, and the latest market developments and trends.